The licensing racket.Meta is not a monopoly.KFF debate on drug pricing in the US. Use of AI by pharmaceutical manufacturers.FDA and agentic AI.
July 24, 2026
- ‘The Child Is Terrified’: Doctors on the Front Lines of a Measles Comeback Speak Out
- To Afford Aging in Place, Older Adults Turn to ‘Golden Girls’ Housing
- Watch: GOP Senator Says Trump’s Tariffs Could Mean Safer Drugs — For a Price
- CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO
Headlines
